论文部分内容阅读
目的探讨Bi PAP呼吸机辅助治疗重症哮喘的临床疗效及可行性。方法选取我院2012年6月至2014年6月收治的重症哮喘患者54例,随机将其分成两组,对照组患者给予常规治疗,试验组则在对照组基础上加用Bi PAP呼吸机进行辅助治疗。比较两组患者的治疗效果及并发症。结果对照组患者总有效率为85.2%,试验组患者总有效率为96.3%,两组比较差异有统计学意义(P<0.05);两组患者均未出现气道损伤、气胸等并发症。结论 Bi PAP呼吸机进行辅助治疗,在提高重症哮喘患者的临床疗效方面有着非常明显的效果,具有较高的可行性。
Objective To investigate the clinical efficacy and feasibility of Bi PAP ventilator assisted therapy for severe asthma. Methods Fifty-four patients with severe asthma admitted to our hospital from June 2012 to June 2014 were randomly divided into two groups. Patients in the control group were given conventional treatment. The experimental group was given Bi PAP ventilator on the basis of the control group Assisted treatment. The curative effect and complication of the two groups were compared. Results The total effective rate was 85.2% in the control group and 96.3% in the experimental group. The difference between the two groups was statistically significant (P <0.05). No airway injury, pneumothorax and other complications occurred in both groups. Conclusion Bi PAP ventilator for adjuvant therapy has a very significant effect in improving the clinical efficacy of patients with severe asthma, with high feasibility.